Shares in Eli Lilly shot up last Thursday after the US pharma major announced positive top-line Phase III results from ...

Denmark-based allergy immunotherapy specialist ALK Abello (ALKB. DC) today announced that its Itulazax (tree pollen ...

The UK’s National Institute for Health and Care Excellence (NICE) has issued positive final guidance recommending Joenja ...

Autoimmune diseases specialist Immunovant has announced changes to its leadership team and the expanded development of its ...

The Trump administration is reportedly revisiting a contentious drug pricing strategy that would tie US medicine prices to ...

Cambridge, USA-based biotech Repertoire Immune Medicines today announced a collaboration and license agreement with Genentech ...

A new report highlights disparities in access to CAR T-cell therapies across Europe, with eligible patient treatment rates as ...

Xlife Sciences says that Veraxa Biotech is to list as a public company on the Nasdaq Global Market through a strategic merger ...

South Korean vaccine developer SK bioscience has won a final ruling in a patent dispute with Moderna (Nasdaq: MRNA) over key ...

German family-owned pharma major Boehringer Ingelheim and Dutch precision oncology company Tessellate Bio have entered into a ...

The biopharmaceutical industry saw a strong start to 2025, despite ongoing uncertainty around the potential impact of US ...

US pharma major Bristol Myers Squibb (NYSE: BMY) saw its shares fall 4% in after-hours trading on Tuesday, after it announced ...